Topical Use of Difinsa53™ to Prevent Radiation Dermatitis

NCT02534129 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Insufficient dermatitis was seen in the controls to allow any determination of protection by Difinsa53

Conditions

Radiodermatitis

Interventions

DRUG: Difinsa53
DRUG: Aquaphor

Sponsor

ProTechSure Scientific, Inc.

Collaborators

[object Object]